3-Hour Virtual Seminar on FDA's Scrutiny of Social Media Promotion

Casper Uldriks Instructor:
Casper Uldriks 
Wednesday, June 1, 2022
09:00 AM PDT | 12:00 PM EDT
3 Hours
Webinar ID: 500533

More Trainings by this Expert

Price Details
Live Webinar
$299 One Attendee
$499 Corporate Live
Recorded Webinar
$349 One Attendee
$549 Corporate Recorded
Combo Offers
Live + Recorded
$559 $648 Live + Recorded
Corporate (Live + Recorded)
$799 $1048 Corporate
(Live + Recorded)

Live: One Dial-in One Attendee

Corporate Live: Any number of participants

Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Overview:

FDA steadily expands the scope and restrictions for promotion of products under its jurisdiction. Whatever and where ever to want to talk about your product, just assume your talking to FDA.

Trolling for off-label information on social media, scrutiny of educational material under "safe harbor" and apparent conflicts of interest at a public event create a sinkhole for firms even though it may seem innocent in your eyes.

Facebook, Twitter or chat rooms can be rampant with off-label information. You even may be surprised about what people are saying about your product. Does FDA hold you accountable?

Why should you Attend:

  • Limitations on commercial free speech
  • Avenues of off-label information
  • Working in a "safe harbor" for off-label information distribution
  • Social media and your regulatory responsibilities
  • Correcting off-label information
  • Factoring in cognitive psychology

Areas Covered in the Session:
  • Learn to navigate through FDA requirements
  • Understand that your right to free speech is limited
  • How to get around FDA prohibitions
  • Ways to manage your presence in social media
  • How to identify an off-label problem and corrective action
  • Under how FDA applies cognitive psychology principles

Who Will Benefit:
  • Regulatory Directors
  • Marketing Directors
  • Quality Systems Auditors
  • Recall Managers
  • In-house Legal Counsel
  • Customer Support Staff
  • Sales Staff


Speaker Profile
Casper (Cap) Uldriks, through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health.

He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value. He understands how FDA thinks, how it operates and where it is headed.

Based on his exceptionally broad experience and knowledge, he can synthesize FDA's domestic and international operational programs, institutional policy and thicket of legal variables into a coherent picture. Professional credentials: JD - Suffolk University, licensed in Massachusetts and the District of Columbia; M.Div in psychology - Boston University with internship through Harvard University.


You Recently Viewed

Subscribe to our Newsletter

Subscribe for Compliance Alerts Research Reports Absolutely Free